Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517500 | SCV000614484 | uncertain significance | not specified | 2016-11-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023517 | SCV005004650 | uncertain significance | Inborn genetic diseases | 2024-03-01 | criteria provided, single submitter | clinical testing | The c.12850A>G (p.T4284A) alteration is located in exon 46 (coding exon 46) of the PKD1 gene. This alteration results from a A to G substitution at nucleotide position 12850, causing the threonine (T) at amino acid position 4284 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005010472 | SCV005638980 | uncertain significance | Polycystic kidney disease, adult type | 2024-04-16 | criteria provided, single submitter | clinical testing |